Literature DB >> 24007689

Shouting through bullet-proof glass: some reflections on pharmacotherapy provision in one Australian clinic.

Sione Crawford.   

Abstract

The Opioid Substitution Treatment Program in New South Wales and Australia has a serious impact on the day to day lives of many people. The program and those consumers who rely upon it are seen with ambivalence by many in the wider community, and many consumers are discriminated against. It seems, to those of us who are engaged in it, that the system itself is confusing and sometimes arbitrary, and that a range of priorities other than clinical need dominate our experience of treatment. These pressures can manifest for us consumers as a punitive and unresponsive treatment experience that, rather than assisting us to live our lives, actually places barriers in our way and ties us up in knots that will take a long time to unravel.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Consumer; Discrimination; Methadone; Stigma

Mesh:

Substances:

Year:  2013        PMID: 24007689     DOI: 10.1016/j.drugpo.2013.07.004

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  6 in total

1.  Factor structure, internal reliability and construct validity of the Methadone Maintenance Treatment Stigma Mechanisms Scale (MMT-SMS).

Authors:  Laramie R Smith; Maria Luisa Mittal; Karla Wagner; Michael M Copenhaver; Chinazo O Cunningham; Valerie A Earnshaw
Journal:  Addiction       Date:  2019-11-27       Impact factor: 6.526

Review 2.  Integrated opioid substitution therapy and HIV care: a qualitative systematic review and synthesis of client and provider experiences.

Authors:  Andy Guise; Maureen Seguin; Gitau Mburu; Susie McLean; Pippa Grenfell; Zahed Islam; Sergii Filippovych; Happy Assan; Andrea Low; Peter Vickerman; Tim Rhodes
Journal:  AIDS Care       Date:  2017-03-10

3.  Examining the relationship between ethnicity and the use of drug-related services: an ethnographic study of Nepali drug users in Hong Kong.

Authors:  Wai-Man Tang
Journal:  Subst Abuse Rehabil       Date:  2014-06-20

4.  "Beyond Safer Injecting"-Health and Social Needs and Acceptance of Support among Clients of a Supervised Injecting Facility.

Authors:  Vendula Belackova; Edmund Silins; Allison M Salmon; Marianne Jauncey; Carolyn A Day
Journal:  Int J Environ Res Public Health       Date:  2019-06-07       Impact factor: 3.390

5.  From client to co-worker: a case study of the transition to peer work within a multi-disciplinary hepatitis c treatment team in Toronto, Canada.

Authors:  Paula Tookey; Kate Mason; Jennifer Broad; Marty Behm; Lise Bondy; Jeff Powis
Journal:  Harm Reduct J       Date:  2018-08-14

6.  Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment.

Authors:  Kirsten Marchand; Julie Foreman; Scott MacDonald; Scott Harrison; Martin T Schechter; Eugenia Oviedo-Joekes
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.